Cargando…
Available Alternative Biologics and Disease Groups Influence Biologic Drug Survival in Patients with Psoriasis and Psoriatic Arthritis
BACKGROUND: Factors other than efficacy and safety could influence the survival of biologics in patients with psoriasis. Little is known about whether different disease groups affect drug survival of biologics or not. OBJECTIVE: This study aimed to investigate whether the availability of alternative...
Autores principales: | Oh, Sohee, Choi, Sungjun, Yoon, Hyun-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561298/ https://www.ncbi.nlm.nih.gov/pubmed/36198623 http://dx.doi.org/10.5021/ad.22.003 |
Ejemplares similares
-
Association Between Short-Term PASI90 Achievement and Drug Survival of Biologics in Patients with Psoriasis
por: Choi, Sungjun, et al.
Publicado: (2022) -
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021) -
Trends in Systemic Psoriasis Treatment: Is Psoriasis Still Being Undertreated?
por: Choi, Sungjun, et al.
Publicado: (2023) -
Quo vadis, biological treatment for psoriasis and psoriatic arthritis?
por: Olszewska, Barbara, et al.
Publicado: (2018) -
Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis
por: Thibodeaux, Quinn, et al.
Publicado: (2019)